Table 2.

Number of Cases, Annual Incidence, and Average Annual Percent Change (AAPC) in Incidence of Spine Metastasis by Age Groups and Sex

Age 25–44 yearsAge 45–64 yearsAge 65–74 yearsAge 75–84 yearsAge ≥ 85 years
YearCountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountCrude annual incidence (95% CI)/MillionAAPC (95% CI)
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (%),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC
(95% CI)
P-value
200717247 (40–54)1.3
(−0.9 to 3.6)
P = .25
842248 (231–265)3.4
(2.4 to 4.3)
P < .01
581654 (601–707)1.0
(0.3 to 1.7)
P < .01
380635 (571–699)2.3
(0.7 to 4.0)
P < .01
58285 (212–358)5.2
(2.3 to 8.3)
P < .01
200815442 (35–49)965276 (258–293)620678 (624–731)398657 (592–721)66307 (233–381)
200917849 (42–56)1024284 (267–302)704745 (690–800)427699 (632–765)67295 (225–366)
201016345 (38–52)1065288 (271–306)693711 (658–764)448724 (657–791)81339 (265–413)
201115944 (37–51)1189316 (298–334)755746 (693–799)465741 (673–808)123494 (406–581)
201220256 (48–64)1176311 (293–328)811757 (705–809)528829 (759–900)111425 (346–504)
201318451 (43–58)1269333 (314–351)849752 (701–802)523808 (739–877)121445 (366–525)
201420757 (49–65)1252326 (308–344)869737 (688–786)528800 (731–868)131466 (386–546)
201519253 (45–60)1329343 (325–362)948773 (724–822)578861 (791–931)117403 (330–476)
201619653 (46–61)1397358 (339–377)1038815 (765–864)602879 (809–950)147485 (407–564)
201720254 (47–62)1436366 (347–385)963727 (681–773)534758 (694–822)158505 (426–583)
201819952 (45–59)1425362 (343–381)1043760 (714–806)589808 (743–874)156484 (408–560)
201919850 (43–57)1490378 (359–397)1118785 (739–831)631834 (769–899)151456 (383–529)
Age 25–44 yearsAge 45–64 yearsAge 65–74 yearsAge 75–84 yearsAge ≥ 85 years
YearCountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountCrude annual incidence (95% CI)/MillionAAPC (95% CI)
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (%),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC
(95% CI)
P-value
200717247 (40–54)1.3
(−0.9 to 3.6)
P = .25
842248 (231–265)3.4
(2.4 to 4.3)
P < .01
581654 (601–707)1.0
(0.3 to 1.7)
P < .01
380635 (571–699)2.3
(0.7 to 4.0)
P < .01
58285 (212–358)5.2
(2.3 to 8.3)
P < .01
200815442 (35–49)965276 (258–293)620678 (624–731)398657 (592–721)66307 (233–381)
200917849 (42–56)1024284 (267–302)704745 (690–800)427699 (632–765)67295 (225–366)
201016345 (38–52)1065288 (271–306)693711 (658–764)448724 (657–791)81339 (265–413)
201115944 (37–51)1189316 (298–334)755746 (693–799)465741 (673–808)123494 (406–581)
201220256 (48–64)1176311 (293–328)811757 (705–809)528829 (759–900)111425 (346–504)
201318451 (43–58)1269333 (314–351)849752 (701–802)523808 (739–877)121445 (366–525)
201420757 (49–65)1252326 (308–344)869737 (688–786)528800 (731–868)131466 (386–546)
201519253 (45–60)1329343 (325–362)948773 (724–822)578861 (791–931)117403 (330–476)
201619653 (46–61)1397358 (339–377)1038815 (765–864)602879 (809–950)147485 (407–564)
201720254 (47–62)1436366 (347–385)963727 (681–773)534758 (694–822)158505 (426–583)
201819952 (45–59)1425362 (343–381)1043760 (714–806)589808 (743–874)156484 (408–560)
201919850 (43–57)1490378 (359–397)1118785 (739–831)631834 (769–899)151456 (383–529)
MalesFemales
YearCountAge-adjusted incidence (95% CI)—/MillionAAPC (95% CI),
P-value
CountAge—standardized incidence (95% CI) -/MillionAAPC (95% CI),
P-value
20071059258 (242–273)2.3
(1.0 to 3.6),
P < .01
974209 (196–223)2.1
(1.3 to 2.9),
P < .01
20081206285 (269–301)997210 (197–223)
20091300299 (283–315)1100226 (213–240)
20101365303 (287–320)1085218 (205–231)
20111473320 (304–337)1218238 (224–251)
20121548329 (312–345)1280246 (232–260)
20131611330 (314–346)1335250 (236–264)
20141622324 (309–340)1365253 (240–267)
20151722336 (320–352)1442261 (247–275)
20161921364 (347–380)1459258 (245–275)
20171829335 (319–350)1464257 (243–270)
20181912339 (324–355)1500258 (245–272)
20191996344 (329–359)1592268 (255–282)
MalesFemales
YearCountAge-adjusted incidence (95% CI)—/MillionAAPC (95% CI),
P-value
CountAge—standardized incidence (95% CI) -/MillionAAPC (95% CI),
P-value
20071059258 (242–273)2.3
(1.0 to 3.6),
P < .01
974209 (196–223)2.1
(1.3 to 2.9),
P < .01
20081206285 (269–301)997210 (197–223)
20091300299 (283–315)1100226 (213–240)
20101365303 (287–320)1085218 (205–231)
20111473320 (304–337)1218238 (224–251)
20121548329 (312–345)1280246 (232–260)
20131611330 (314–346)1335250 (236–264)
20141622324 (309–340)1365253 (240–267)
20151722336 (320–352)1442261 (247–275)
20161921364 (347–380)1459258 (245–275)
20171829335 (319–350)1464257 (243–270)
20181912339 (324–355)1500258 (245–272)
20191996344 (329–359)1592268 (255–282)
Table 2.

Number of Cases, Annual Incidence, and Average Annual Percent Change (AAPC) in Incidence of Spine Metastasis by Age Groups and Sex

Age 25–44 yearsAge 45–64 yearsAge 65–74 yearsAge 75–84 yearsAge ≥ 85 years
YearCountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountCrude annual incidence (95% CI)/MillionAAPC (95% CI)
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (%),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC
(95% CI)
P-value
200717247 (40–54)1.3
(−0.9 to 3.6)
P = .25
842248 (231–265)3.4
(2.4 to 4.3)
P < .01
581654 (601–707)1.0
(0.3 to 1.7)
P < .01
380635 (571–699)2.3
(0.7 to 4.0)
P < .01
58285 (212–358)5.2
(2.3 to 8.3)
P < .01
200815442 (35–49)965276 (258–293)620678 (624–731)398657 (592–721)66307 (233–381)
200917849 (42–56)1024284 (267–302)704745 (690–800)427699 (632–765)67295 (225–366)
201016345 (38–52)1065288 (271–306)693711 (658–764)448724 (657–791)81339 (265–413)
201115944 (37–51)1189316 (298–334)755746 (693–799)465741 (673–808)123494 (406–581)
201220256 (48–64)1176311 (293–328)811757 (705–809)528829 (759–900)111425 (346–504)
201318451 (43–58)1269333 (314–351)849752 (701–802)523808 (739–877)121445 (366–525)
201420757 (49–65)1252326 (308–344)869737 (688–786)528800 (731–868)131466 (386–546)
201519253 (45–60)1329343 (325–362)948773 (724–822)578861 (791–931)117403 (330–476)
201619653 (46–61)1397358 (339–377)1038815 (765–864)602879 (809–950)147485 (407–564)
201720254 (47–62)1436366 (347–385)963727 (681–773)534758 (694–822)158505 (426–583)
201819952 (45–59)1425362 (343–381)1043760 (714–806)589808 (743–874)156484 (408–560)
201919850 (43–57)1490378 (359–397)1118785 (739–831)631834 (769–899)151456 (383–529)
Age 25–44 yearsAge 45–64 yearsAge 65–74 yearsAge 75–84 yearsAge ≥ 85 years
YearCountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountCrude annual incidence (95% CI)/MillionAAPC (95% CI)
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (95% CI),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC (%),
P-value
CountAnnual incidence (95% CI) -/MillionAAPC
(95% CI)
P-value
200717247 (40–54)1.3
(−0.9 to 3.6)
P = .25
842248 (231–265)3.4
(2.4 to 4.3)
P < .01
581654 (601–707)1.0
(0.3 to 1.7)
P < .01
380635 (571–699)2.3
(0.7 to 4.0)
P < .01
58285 (212–358)5.2
(2.3 to 8.3)
P < .01
200815442 (35–49)965276 (258–293)620678 (624–731)398657 (592–721)66307 (233–381)
200917849 (42–56)1024284 (267–302)704745 (690–800)427699 (632–765)67295 (225–366)
201016345 (38–52)1065288 (271–306)693711 (658–764)448724 (657–791)81339 (265–413)
201115944 (37–51)1189316 (298–334)755746 (693–799)465741 (673–808)123494 (406–581)
201220256 (48–64)1176311 (293–328)811757 (705–809)528829 (759–900)111425 (346–504)
201318451 (43–58)1269333 (314–351)849752 (701–802)523808 (739–877)121445 (366–525)
201420757 (49–65)1252326 (308–344)869737 (688–786)528800 (731–868)131466 (386–546)
201519253 (45–60)1329343 (325–362)948773 (724–822)578861 (791–931)117403 (330–476)
201619653 (46–61)1397358 (339–377)1038815 (765–864)602879 (809–950)147485 (407–564)
201720254 (47–62)1436366 (347–385)963727 (681–773)534758 (694–822)158505 (426–583)
201819952 (45–59)1425362 (343–381)1043760 (714–806)589808 (743–874)156484 (408–560)
201919850 (43–57)1490378 (359–397)1118785 (739–831)631834 (769–899)151456 (383–529)
MalesFemales
YearCountAge-adjusted incidence (95% CI)—/MillionAAPC (95% CI),
P-value
CountAge—standardized incidence (95% CI) -/MillionAAPC (95% CI),
P-value
20071059258 (242–273)2.3
(1.0 to 3.6),
P < .01
974209 (196–223)2.1
(1.3 to 2.9),
P < .01
20081206285 (269–301)997210 (197–223)
20091300299 (283–315)1100226 (213–240)
20101365303 (287–320)1085218 (205–231)
20111473320 (304–337)1218238 (224–251)
20121548329 (312–345)1280246 (232–260)
20131611330 (314–346)1335250 (236–264)
20141622324 (309–340)1365253 (240–267)
20151722336 (320–352)1442261 (247–275)
20161921364 (347–380)1459258 (245–275)
20171829335 (319–350)1464257 (243–270)
20181912339 (324–355)1500258 (245–272)
20191996344 (329–359)1592268 (255–282)
MalesFemales
YearCountAge-adjusted incidence (95% CI)—/MillionAAPC (95% CI),
P-value
CountAge—standardized incidence (95% CI) -/MillionAAPC (95% CI),
P-value
20071059258 (242–273)2.3
(1.0 to 3.6),
P < .01
974209 (196–223)2.1
(1.3 to 2.9),
P < .01
20081206285 (269–301)997210 (197–223)
20091300299 (283–315)1100226 (213–240)
20101365303 (287–320)1085218 (205–231)
20111473320 (304–337)1218238 (224–251)
20121548329 (312–345)1280246 (232–260)
20131611330 (314–346)1335250 (236–264)
20141622324 (309–340)1365253 (240–267)
20151722336 (320–352)1442261 (247–275)
20161921364 (347–380)1459258 (245–275)
20171829335 (319–350)1464257 (243–270)
20181912339 (324–355)1500258 (245–272)
20191996344 (329–359)1592268 (255–282)
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close